http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36333248

Outgoing Links

Predicate Object
contentType Journal Article
issn 2296-858X
pageRange 1192971-
publicationName Frontiers in Medicine
startingPage 1192971
bibliographicCitation Dong W, Liang Y, Li D, Ma Z, Cheng M, Zhang X, Shen J, Zhou N, Hao J, Jiang W, Hu Z. The effect of sequential perioperative intravenous tranexamic acid in reducing postoperative blood loss and hidden blood loss after posterior lumbar interbody fusion: a randomized controlled trial. Front Med (Lausanne). 2023;10():1192971. PMID: 37601774; PMCID: PMC10436300.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edea0a09e72fa83ee372d7b1311ca414
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c6931b1b49ab522337f1f2f174fbeab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c124b4e9502a123085de9ca4754e3ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99da2314b21bac6880741fd48b484003
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c07676ccfc75dd4eea52a411d281c9a5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9450f169111b16a697b1c9b7b638e109
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bbae84483992bebdd90bdf4296736d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c38b86e633434ee9f2881ac6ff826d45
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1054f1e3cdc698b49f32477c339c7d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fee85f8fbc5fa6bcd9cf80d2a6bb37e
date 2023-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/37601774
https://pubmed.ncbi.nlm.nih.gov/PMC10436300
https://doi.org/10.3389/fmed.2023.1192971
isPartOf https://portal.issn.org/resource/ISSN/2296-858X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43407
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title The effect of sequential perioperative intravenous tranexamic acid in reducing postoperative blood loss and hidden blood loss after posterior lumbar interbody fusion: a randomized controlled trial
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1234fa03f415956a18d248bb3471ba0b
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5526
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9643

Total number of triples: 35.